Answers are grounded in this paper and cite their sources.
Retrospective study evaluates DCE-MRI's predictive value for prognosis in triple-negative breast cancer, indicating significant findings.
This study aimed to evaluate the predictions of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for prognosis of triple-negative breast cancer (TNBC), especially with residual disease (RD) after preoperative chemotherapy. This retrospective analysis included 74 TNBC patients who received preoperative chemotherapy. DCE-MRI findings from three timepoints were examined: at diagnosis (MRI pre ), at midpoint (MRI mid ) and after chemotherapy (MRI post ). These findings included cancer lesion size, washout index (WI) as a kinetic parameter using the difference in signal intensity between early and delayed phases, and time-signal intensity curve types. Distant disease-free survival was analysed using the log-rank test to compare RD group with and without a fast-washout curve. The diagnostic performance of DCE-MRI findings, including positive predictive value (PPV) for pathological responses, was also calculated. RD without fast washout curve was a significantly better prognostic factor, both at MRI mid and MRI post (hazard ratio = 0.092, 0.098, p < 0.05). PPV for pathological complete remission at MRI mid was 76.7% by the cut-off point at negative WI value or lesion size = 0, and 66.7% at lesion size = 0. WI and curve types derived from DCE-MRI at the midpoint of preoperative chemotherapy can help not only assess tumour response but also predict prognosis.
No takes yet. Share an insight, caveat, or question.
Yamaguchi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: